drugset
drugset / Trial / NCT06471868

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC

NCT06471868 ↗

Phase 1 Unknown 60 enrolled Il-Yang Pharm. Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

This study evaluate the pharmacokinetic and safety of IY-HCR21

Timeline

Start
2024-06-10
Primary completion
2024-06-25
Completion
2024-07-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betanechol Unknown 25 mg —
Comparator Betanechol Unknown 50 mg —

Indications

No indication recorded.